3.15

2.27% 0.07

After Hours: 3.13 -0.02 -0.63%

Maravai Lifesciences Holdings Inc (MRVI)

Overview News Price History Option Chain Financials Why MRVI Down? Discussions Forecast

Maravai Lifesciences Holdings Inc stock is traded at $3.15, with a volume of 3.63M. It is up +2.27% in the last 24 hours and up +6.42% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Previous Close:

$3.08

Open:

$3.13

24h Volume:

3.63M

Relative Volume:

2.86

Market Cap:

$461.11M

Revenue:

$185.74M

Net Income/Loss:

$-230.76M

P/E Ratio:

-3.4772

EPS:

-0.9059

Net Cash Flow:

$-70.72M

1W Performance:

-13.22%

1M Performance:

+6.42%

6M Performance:

+9.00%

1Y Performance:

+28.57%

1-Day Range:

$3.00

$3.17

1-Week Range:

$3.00

$3.73

52-Week Range:

$1.665

$4.105

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name

Maravai Lifesciences Holdings Inc

Sector

Healthcare (1116)

Industry

Biotechnology (621)

Phone

(858) 546-0004

Address

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Employee

435

Twitter

Next Earnings Date

2025-03-18

Latest SEC Filings

MRVI's Discussions on Twitter

Compare MRVI vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MRVI Maravai Lifesciences Holdings Inc	3.15	450.86M	185.74M	-230.76M	-70.72M	-0.9059
VRTX Vertex Pharmaceuticals Inc	466.10	119.23B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	756.91	78.84B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	703.30	43.35B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	318.91	41.57B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	289.65	31.51B	5.36B	287.73M	924.18M	2.5229

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-26-25	Downgrade	Robert W. Baird	Outperform → Neutral
Dec-19-24	Initiated	Guggenheim	Neutral
Dec-05-24	Downgrade	Goldman	Neutral → Sell
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-10-24	Initiated	Craig Hallum	Buy
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-15-20	Initiated	BofA Securities	Buy
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	Goldman	Buy
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Robert W. Baird	Outperform
Dec-15-20	Initiated	Stifel	Buy
Dec-15-20	Initiated	William Blair	Outperform
Dec-14-20	Initiated	UBS	Buy

View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

12:00 PM

Maravai LifeSciences (NASDAQ:MRVI) Sees Large Volume IncreaseStill a Buy? - MarketBeat

12:00 PM

Mar 15, 2026

2026-03-15 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation | NDAQ:MRVI | Press Release - Stockhouse

Mar 15, 2026

Mar 12, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation - ACCESS Newswire

Mar 12, 2026

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of “Hold” by Analysts - Defense World

Mar 12, 2026

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Mar 12, 2026

Mar 09, 2026

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out - ACCESS Newswire

Mar 09, 2026

Mar 08, 2026

Maravai LifeSciences Holdings Q1 2025 Earnings Preview - MSN

Mar 08, 2026

Mar 07, 2026

How rising interest rates impact Maravai LifeSciences Holdings Inc. stockEntry Point & Precise Trade Entry Recommendations - Naître et grandir

Mar 07, 2026

How does Maravai LifeSciences Holdings Inc score in quality rankings2025 Big Picture & Fast Momentum Entry Tips - baoquankhu1.vn

Mar 07, 2026

Mar 05, 2026

Targets Report: What are Maravai LifeSciences Holdings Incs earnings expectations2025 Price Targets & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn

Mar 05, 2026